The American College of Cardiology announced it is developing a program to prevent hospital readmissions among heart disease patients.
The Patient Navigator Program, which is supported by a $10 million sponsorship from AstraZeneca, will include a team of providers to smooth patients' transition from hospital to home. Thirty-five hospitals that are part of the ACC's National Cardiovascular Data Registry and the Hospital to Home Initiative will participate in the new program, using tools and strategies they have learned from the ACC initiatives to prevent readmissions.
The ACC aims for the program to support a culture of patient-centered care and spread to hospitals across the country, according to the news release.
3 Ways to Make Readmission Rates a More Useful Quality Measure
Why Hospitals Need to Look Beyond 30-Day Readmissions
The Patient Navigator Program, which is supported by a $10 million sponsorship from AstraZeneca, will include a team of providers to smooth patients' transition from hospital to home. Thirty-five hospitals that are part of the ACC's National Cardiovascular Data Registry and the Hospital to Home Initiative will participate in the new program, using tools and strategies they have learned from the ACC initiatives to prevent readmissions.
The ACC aims for the program to support a culture of patient-centered care and spread to hospitals across the country, according to the news release.
More Articles on Hospital Readmissions:
Joint Commission Launches Readmission Reduction Consulting Service3 Ways to Make Readmission Rates a More Useful Quality Measure
Why Hospitals Need to Look Beyond 30-Day Readmissions